Who is a candidate for iTind?

Typical patient profile

• Moderate to severe lower urinary tract symptoms from benign prostatic hyperplasia (BPH).
• Prostate size is suitable for the device. Published studies describe iTind most often in prostates under approximately 60 cc, though it has been used in larger glands.¹
• A desire to preserve sexual and ejaculatory function.^{2, 3, 4}
• Preference to avoid, pause or step down from long-term BPH medication.
• Preference to avoid a permanent implant in the prostate.
• Preference for a procedure with no overnight hospital stay.

Situations where iTind is less likely to be appropriate

• Very large prostates, particularly those with a prominent median lobe, may be better suited to other procedures.
• Active urinary tract infection or untreated bladder pathology should be addressed first.
• Men in urinary retention, depending on individual circumstances, may need a different approach.
• Anatomy or comorbidities that make safe cystoscopic placement difficult.

These are general principles, not a checklist for self-assessment. Only a urologist who has reviewed your history, flow study, ultrasound and cystoscopy can judge eligibility.

How iTind sits next to other BPH options

The main BPH procedures offered by Dr Kooner also include UroLift, Rezum, Holmium laser enucleation and transurethral resection (TURP). They differ in mechanism, in whether anything is left behind in the prostate, and in how they are expected to affect sexual function.

A side-by-side comparison is only a guide. Your urologist will weigh flow studies, prostate size and shape, bladder function, sexual function goals and overall health before recommending an option.